JP2009514840A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009514840A5 JP2009514840A5 JP2008538419A JP2008538419A JP2009514840A5 JP 2009514840 A5 JP2009514840 A5 JP 2009514840A5 JP 2008538419 A JP2008538419 A JP 2008538419A JP 2008538419 A JP2008538419 A JP 2008538419A JP 2009514840 A5 JP2009514840 A5 JP 2009514840A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- mucosal
- parenteral
- influenza
- kit according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 claims 26
- 229960003971 influenza vaccine Drugs 0.000 claims 15
- 241000700605 Viruses Species 0.000 claims 4
- 241000712461 unidentified influenza virus Species 0.000 claims 4
- 238000004113 cell culture Methods 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 229960001226 live attenuated influenza Drugs 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 229940031551 inactivated vaccine Drugs 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 238000011269 treatment regimen Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73402605P | 2005-11-04 | 2005-11-04 | |
| US83633206P | 2006-08-07 | 2006-08-07 | |
| PCT/GB2006/004132 WO2007052057A2 (en) | 2005-11-04 | 2006-11-06 | Adminstration routes for priming/boosting with influenza vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009514840A JP2009514840A (ja) | 2009-04-09 |
| JP2009514840A5 true JP2009514840A5 (enExample) | 2009-10-15 |
Family
ID=37862714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538419A Pending JP2009514840A (ja) | 2005-11-04 | 2006-11-06 | インフルエンザワクチンによってプライム（ｐｒｉｍｉｎｇ）／ブースト（ｂｏｏｓｔｉｎｇ）するための投与経路 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100158943A1 (enExample) |
| EP (1) | EP1945253A2 (enExample) |
| JP (1) | JP2009514840A (enExample) |
| AU (1) | AU2006310338A1 (enExample) |
| CA (1) | CA2628379A1 (enExample) |
| NZ (1) | NZ567980A (enExample) |
| WO (1) | WO2007052057A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090016704A (ko) | 2006-06-15 | 2009-02-17 | 노파르티스 아게 | 보조제-보존 수회-투여 인플루엔자 접종 요법 |
| ES2539818T3 (es) | 2007-08-02 | 2015-07-06 | Biondvax Pharmaceuticals Ltd. | Vacunas contra la gripe multiepitópicas multiméricas |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
| WO2009071633A1 (en) * | 2007-12-06 | 2009-06-11 | Glaxosmithkline Biologicals S.A. | Influenza composition |
| EA201071086A1 (ru) | 2008-03-18 | 2011-04-29 | Новартис Аг | Усовершенствованный способ получения вакцинных антигенов вируса гриппа |
| WO2009156852A1 (en) * | 2008-06-25 | 2009-12-30 | Novartis Ag | Rapid responses to delayed booster immunisations |
| US20120093859A1 (en) | 2009-02-10 | 2012-04-19 | Novartis Ag | Influenza vaccine regimens for pandemic-associated strains |
| EP3173097A3 (en) | 2009-02-10 | 2017-07-12 | Seqirus UK Limited | Influenza vaccines with reduced amounts of squalene |
| EP2596017B1 (en) * | 2010-07-22 | 2019-04-03 | John W. Schrader | Cross-protective antibody against influenza viral infection |
| US9821051B1 (en) | 2010-10-28 | 2017-11-21 | Seqirus UK Limited | Reducing hospitalization in elderly influenza vaccine recipients |
| WO2012114323A1 (en) * | 2011-02-22 | 2012-08-30 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| JP2016502995A (ja) * | 2012-12-17 | 2016-02-01 | ユーロシネ ヴァクシンズ アクチエボラーグ | 鼻腔内予防接種投薬レジメン |
| US10335435B2 (en) | 2015-05-22 | 2019-07-02 | Marco Merida | Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach |
| BR112017028011A2 (pt) | 2015-06-26 | 2018-08-28 | Seqirus Uk Ltd | vacinas de gripe correspondentes antigenicamente |
| CA3080656A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500513A (en) * | 1979-05-15 | 1985-02-19 | Miles Laboratories, Inc. | Influenza vaccine production in liquid cell culture |
| US5643574A (en) * | 1993-10-04 | 1997-07-01 | Albany Medical College | Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| US6818222B1 (en) * | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| JP2003509473A (ja) * | 1999-09-24 | 2003-03-11 | スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム | ワクチン |
| GB9923176D0 (en) * | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| ATE426412T1 (de) * | 2003-01-30 | 2009-04-15 | Novartis Vaccines & Diagnostic | Adjuvante influenza-vakzine |
| US20040213745A1 (en) * | 2003-02-20 | 2004-10-28 | Vincent Sullivan | Powder formulations of rSEB for improved vaccination |
-
2006
- 2006-11-06 WO PCT/GB2006/004132 patent/WO2007052057A2/en not_active Ceased
- 2006-11-06 JP JP2008538419A patent/JP2009514840A/ja active Pending
- 2006-11-06 EP EP06808427A patent/EP1945253A2/en not_active Withdrawn
- 2006-11-06 AU AU2006310338A patent/AU2006310338A1/en not_active Abandoned
- 2006-11-06 CA CA002628379A patent/CA2628379A1/en not_active Abandoned
- 2006-11-06 NZ NZ567980A patent/NZ567980A/en not_active IP Right Cessation
- 2006-11-06 US US12/092,225 patent/US20100158943A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Azegami et al. | Challenges in mucosal vaccines for the control of infectious diseases | |
| JP2009514840A5 (enExample) | ||
| Plotkin et al. | The development of vaccines: how the past led to the future | |
| AU646257B2 (en) | Oral vaccine comprising antigen surface-associated with red blood cells | |
| ES2271969T3 (es) | Vacunas dtp-polio multivalentes. | |
| Qu et al. | Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice | |
| Czerkinsky et al. | Sublingual vaccination | |
| ES2257769T3 (es) | Metodo para la preparacion de vacunas multivalentes. | |
| JP2009539965A5 (enExample) | ||
| Courtney et al. | Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens | |
| TWI630915B (zh) | 無細胞百日咳疫苗 | |
| MY180698A (en) | Immunization protocol against the 4 dengue serotypes | |
| CN103933564A (zh) | 疫苗 | |
| EA201171032A1 (ru) | Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами | |
| JP2004536106A5 (enExample) | ||
| WO2013000905A1 (en) | Canine coronavirus vaccine | |
| JP5712126B2 (ja) | 遅延型追加刺激免疫処置に対する迅速な応答 | |
| CA2646574A1 (en) | Vaccine against mycoplasma and prrsv | |
| JP2003513935A5 (enExample) | ||
| RU2012153061A (ru) | Конъюгаты для предупреждения или лечения никотиновой зависимости | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| DE60331412D1 (de) | Hiv-vakzine und anwendungsverfahren | |
| JP2021500325A (ja) | 血清型３線毛を発現するボルデテラ（ｂｏｒｄｅｔｅｌｌａ）菌株 | |
| JP2013525295A (ja) | ワクチン接種方法 | |
| RU2008144180A (ru) | Вакцина против микоплазмы и prrsv |